Md. Sahab Uddin
Impact in
- Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
-
- Medicinal Plants and Neuroprotection
Papers in
- Physiology 51
- Alzheimer's disease research and treatments 41
- Co-authors
- Ghulam Md Ashraf (61 shared papers)Md. Tanvir Kabir (46 shared papers)Mohamed M. Abdel‐Daim (41 shared papers)Abdullah Al Mamun (37 shared papers)Bijo Mathew (32 shared papers)George E. Barreto (17 shared papers)Lotfi Aleya (15 shared papers)May Bin‐Jumah (22 shared papers)
- Journals
- Current Pharmaceutical Design (14 papers)Molecular Neurobiology (9 papers)Environmental Science and Pollution Research (9 papers)Current Protein and Peptide Science (7 papers)Current Gene Therapy (6 papers)
- Partner nations
- BangladeshSaudi ArabiaIndia
In The Last Decade
Md. Sahab Uddin
185 papers receiving 8.3k citations
Md. Sahab Uddin's Hit Papers
Peers
Comparison fields: 5 of 185
- Biological Psychiatry 403
- Complementary and alternative medicine 701
- Physiology 2.1k
- Biochemistry 524
- Neurology 688
Countries citing papers authored by Md. Sahab Uddin
This map shows the geographic impact of Md. Sahab Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Sahab Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Sahab Uddin more than expected).
Fields of papers citing papers by Md. Sahab Uddin
This network shows the impact of papers produced by Md. Sahab Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Sahab Uddin. The network helps show where Md. Sahab Uddin may publish in the future.
Co-authors
The 25 scholars most cited alongside Md. Sahab Uddin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects Hit paper breakdown → | 2021 | 541 |
| 2 | Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications Hit paper breakdown → | 2018 | 329 |
| 3 | 2019 | 271 | |
| 4 | 2019 | 236 | |
| 5 | 2019 | 224 | |
| 6 | 2018 | 153 | |
| 7 | 2021 | 152 | |
| 8 | 2020 | 150 | |
| 9 | 2021 | 146 | |
| 10 | 2021 | 145 | |
| 11 | 2020 | 142 | |
| 12 | 2020 | 131 | |
| 13 | 2020 | 131 | |
| 14 | 2019 | 126 | |
| 15 | 2021 | 125 | |
| 16 | 2020 | 124 | |
| 17 | 2019 | 122 | |
| 18 | 2020 | 122 | |
| 19 | 2019 | 120 | |
| 20 | 2020 | 120 |
About Md. Sahab Uddin
Md. Sahab Uddin is a scholar working on Physiology, Molecular Biology, Pharmacology, Endocrinology, Diabetes and Metabolism and Plant Science, having authored 188 papers that have together received 8.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (41 papers), Cholinesterase and Neurodegenerative Diseases (24 papers), Natural Antidiabetic Agents Studies (14 papers), Computational Drug Discovery Methods (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Tryptophan and brain disorders (9 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Biological Psychiatry (403 citations), Complementary and alternative medicine (701 citations), Physiology (2.1k citations), Biochemistry (524 citations) and Neurology (688 citations). Md. Sahab Uddin has collaborated with scholars based in Bangladesh, Saudi Arabia and India. Frequent co-authors include Ghulam Md Ashraf, Md. Tanvir Kabir, Mohamed M. Abdel‐Daim, Abdullah Al Mamun, Bijo Mathew, George E. Barreto, Lotfi Aleya, May Bin‐Jumah, Philippe Jeandet and Devesh Tewari. Their work appears in journals such as Current Pharmaceutical Design, Molecular Neurobiology, Environmental Science and Pollution Research, Current Protein and Peptide Science and Current Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.